Figshareopen access

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?

Name: Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?
License: Open Access

Dan Xu (23288218) et al.

Figshare · Datasets · License: Open Access

Open Source ↗

medicine

science & technology, life sciences & biomedicine, medicine, general & internal, general & internal medicine, sglt2i inhibitor, primary prevention, cardioprotection, renoprotection

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?

Related documents